Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Study Title

Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Teva Identifier

TVP - 1012/233

ClinicalTrials.gov Identifier

NCT00203138

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: rasagiline mesylate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

35 Years and older

Trial Duration

06/01/2004 - 12/01/2006

Phase

Phase 3

Study Type

Interventional